Targeting HDAC Complexes in Asthma and COPD

Around three million patients die due to airway inflammatory diseases each year. The most notable of these diseases are asthma and chronic obstructive pulmonary disease (COPD). Therefore, new therapies are urgently needed. Promising targets are histone deacetylases (HDACs), since they regulate postt...

Descripción completa

Detalles Bibliográficos
Autores principales: Zwinderman, Martijn R. H., de Weerd, Sander, Dekker, Frank J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594684/
https://www.ncbi.nlm.nih.gov/pubmed/34968229
http://dx.doi.org/10.3390/epigenomes3030019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594684/
https://www.ncbi.nlm.nih.gov/pubmed/34968229
http://dx.doi.org/10.3390/epigenomes3030019

Ejemplares similares